Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

被引:241
作者
LeBrasseur, Nathan K.
Kelly, Meghan
Tsao, Tsu-Shuen
Farmer, Stephen R.
Saha, Asish K.
Ruderman, Neil B.
Tomas, Eva
机构
[1] Boston Univ, Sch Med, Diabet & Metab Res Unit, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[3] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2006年 / 291卷 / 01期
关键词
acetyl-coenzyme A carboxylase; adiponectin; diabetes; insulin sensitivity; metabolism;
D O I
10.1152/ajpendo.00453.2005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291: E175-E181, 2006. First published February 7, 2006; doi: 10.1152/ajpendo. 00453.2005.-Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPAR gamma in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase ( AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPAR gamma-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 mu M troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 mu M, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-D-glucose uptake and the oxidation of exogenous [C-14] palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPAR gamma to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPAR gamma-mediated gene transcription.
引用
收藏
页码:E175 / E181
页数:7
相关论文
共 48 条
[1]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[2]   Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats [J].
Bergeron, R ;
Previs, SF ;
Cline, GW ;
Perret, P ;
Russell, RR ;
Young, LH ;
Shulman, GI .
DIABETES, 2001, 50 (05) :1076-1082
[3]   A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat [J].
Brown, KK ;
Henke, BR ;
Blanchard, SG ;
Cobb, JE ;
Mook, R ;
Kaldor, I ;
Kliewer, SA ;
Lehmann, JM ;
Lenhard, JM ;
Harrington, WW ;
Novak, PJ ;
Faison, W ;
Binz, JG ;
Hashim, MA ;
Oliver, WO ;
Brown, HR ;
Parks, DJ ;
Plunket, KD ;
Tong, WQ ;
Menius, JA ;
Adkison, K ;
Noble, SA ;
Willson, TM .
DIABETES, 1999, 48 (07) :1415-1424
[4]   Thiazolidinediones, like metformin, inhibit respiratory complex I -: A common mechanism contributing to their antidiabetic actions? [J].
Brunmair, B ;
Staniek, K ;
Gras, F ;
Scharf, N ;
Althaym, A ;
Clara, R ;
Roden, M ;
Gnaiger, E ;
Nohl, H ;
Waldhäusl, W ;
Fürnsinn, C .
DIABETES, 2004, 53 (04) :1052-1059
[5]   Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-γ-mediated changes in gene expression [J].
Brunmair, B ;
Gras, F ;
Neschen, S ;
Roden, M ;
Wagner, L ;
Waldhäusl, W ;
Fürnsinn, C .
DIABETES, 2001, 50 (10) :2309-2315
[6]   Troglitazone action is independent of adipose tissue [J].
Burant, CF ;
Sreenan, S ;
Hirano, KI ;
Tai, TAC ;
Lohmiller, J ;
Lukens, J ;
Davidson, NO ;
Ross, S ;
Graves, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2900-2908
[7]  
CASTELEIN H, 1994, J BIOL CHEM, V269, P26754
[8]   Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonists [J].
Cha, BS ;
Ciaraldi, TP ;
Park, KS ;
Carter, L ;
Mudaliar, SR ;
Henry, RR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (01) :E151-E159
[9]   Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe [J].
Colca, JR ;
McDonald, WG ;
Waldon, DJ ;
Leone, JW ;
Lull, JM ;
Bannow, CA ;
Lund, ET ;
Mathews, WR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (02) :E252-E260
[10]   Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma [J].
DeVos, P ;
Lefebvre, AM ;
Miller, SG ;
GuerreMillo, M ;
Wong, K ;
Saladin, R ;
Hamann, LG ;
Staels, B ;
Briggs, MR ;
Auwerx, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1004-1009